Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.

In this episode Tim chats with Brian Leedman, chairman of NeuroScientific Biopharmaceuticals (ASX:NSB).

NSB is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.

Of particular focus for the company are a number of neurological disorders and diseases of the eye.

NSB made headlines earlier in 2021 with the announcement that it was researching a potential cure for post-COVID lung damage.

So tune in below to hear about all things NeuroScientific.

On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.

Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!

Read MoreCOVID-19Drug Development

Featured Companies

You might be interested in